Lung Cancer
Conditions
Interventions
results 
based 
on 
Sponsors
The First Affiliated Hospital of Nanjing Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with pulmonary space occupying lesions on imaging; 2. The patients who have not received anti-tumor therapy and the nature of the lesions have not been confirmed; 3. Patients with malignant possibility judged by clinicians need to be judged by other means; 4. Patients who agree to obtain tissue through percutaneous lung puncture or electronic bronchoscopy, thoracoscopy and other examinations should make a clear diagnosis of the source and nature of pathology according to the "gold standard" of pathology.
Exclusion criteria
Exclusion criteria: 1. Due to the patient's own reasons or the current means, it is impossible to determine the source or nature of pathology by the "gold standard" of pathology; 2. Patients who can not get the results of platelet nucleic acid test for various reasons; 3. Patients with various primary malignant tumor diseases were diagnosed by pathology.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| platelet nucleic acid;SEN, SPE, ACC, AUC of ROC; | — |
Countries
China
Contacts
Public ContactHongwei Liang
China Pharmaceutical University
Outcome results
None listed